Marinol Patient, Information, Instructions - Dronabinol

Marinol Patient, Information, Instructions - Dronabinol

PATIENT INFORMATION

Patients receiving treatment with MARINOL^® (Dronabinol) Capsules should be alerted to the potential for additive central nervous system depression if MARINOL^® Capsules is used concomitantly with alcohol or other CNS depressants such as benzodiazepines and barbiturates.

Patients receiving treatment with MARINOL^® Capsules should be specifically warned not to drive, operate machinery, or engage in any hazardous activity until it is established that they are able to tolerate the drug and to perform such tasks safely.

Patients using MARINOL^® Capsules should be advised of possible changes in mood and other adverse behavioral effects of the drug so as to avoid panic in the event of such manifestations. Patients should remain under the supervision of a responsible adult during initial use of MARINOL^® Capsules and following dosage adjustments.